PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26026F0028 — PHARM - LUMRYZ

PHARM - LUMRYZ is a federal award for Department of Veterans Affairs (VA) held by AVADEL CNS PHARMACEUTICALS, LLC. Estimated value $160K ($160K obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: MEMPHIS TN.

$160K
Estimated Value
Sep 30, 2026
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

AVADEL CNS PHARMACEUTICALS, LLC holds $34K across 7 federal awards, concentrated at Department of Veterans Affairs (VA). The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

Federal
Contract number36C26026F0028
AgencyDepartment of Veterans Affairs (VA)
IncumbentAVADEL CNS PHARMACEUTICALS, LLC
CAGE9MEL2
UEIL6XLUBSCA6T5
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79725D0095
Place of performanceMEMPHIS TN
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startOct 1, 2025
PoP end (current)Sep 30, 2026
Obligated$160K
Current value$160K
Potential value$160K

Recompete timing

Public
Expiring in 41 days

Current PoP ends Sep 30, 2026 (41 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

AVADEL CNS PHARMACEUTICALS, LLC$34K obligated across 7 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$34K · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 36C26026F0028
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open AVADEL CNS PHARMACEUTICALS, LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 36C26026F0028?

36C26026F0028 (PHARM - LUMRYZ) is a Department of Veterans Affairs (VA) award with an estimated value of $160K, currently held by AVADEL CNS PHARMACEUTICALS, LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 36C26026F0028?

AVADEL CNS PHARMACEUTICALS, LLC is the incumbent with $34K across 7 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does 36C26026F0028 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36F79725D0095-36C26026F0028

SCOUT Signal

August 2026

One VA health contract was 35% of civilian federal obligations in July.

Meanwhile VA's service-disabled veteran-owned contract actions fell 41.8%. The same agency, the same month, the large-vendor lane expanding while the small-business lane contracted. Figures are civilian-agency obligations through 2026-07-31; DoD FPDS for this window is labeled incomplete.

This issue is the whole civilian market. Your capture plan isn't.

Read the August 2026 issue →